Cancer Immunotherapy Market Is Expected to Reach US $124.88 Bn by 2024 - Pipeline and Player Performance Improvements Seem Highly Promising
The growing incidences of cancer and a need to treat them is the key driver of the global immunotherapy market. The number of deaths occurring due to cancer is increasing every year and has therefore forced government bodies to take initiatives for the improvement of the health conditions of people, by investing heavily in research and development and enabling innovation and advancements in technology so as to offer improved treatments. This has pushed the growth of the global cancer immunotherapy...
View full press release